We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HNR1:XETRHannover Rueck SE Analysis

Data as of 2026-03-11 - not real-time

€248.40

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Hannover Rück is trading at €248.4, just above its near‑term support of €241.6 and modestly below its 20‑day SMA of €249.9, indicating limited upside in the immediate window. The stock benefits from a *PE ratio of 12.1*—well under the industry average of 17.3—combined with a **ROE of over 20%**, a solid dividend yield of 2.84% and a low beta of 0.21, underscoring its defensive profile. Recent headlines confirm a strong earnings beat, a raised earnings target and a 1.5% price lift, while analysts highlight growth avenues in cyber‑risk and natural‑catastrophe reinsurance, pushing the consensus target toward €312.
Given the DCF‑derived fair value of €409 and a modest 14% upside relative to current pricing, the equity appears **undervalued** despite a neutral technical stance (RSI ~49, bearish MACD histogram). The balance sheet is sound with a moderate debt‑to‑equity of 32.5% and a sustainable payout ratio of 34%, supporting confidence in continued dividend payments and long‑term capital appreciation.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Recent earnings beat and raised target
  • Attractive dividend yield with low payout ratio
  • Price near support with limited downside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervaluation relative to peers (PE 12 vs 17)
  • Growth tailwinds in cyber and natural‑catastrophe lines
  • Strong ROE and cash‑flow generation

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable dividend backed by solid cash flow
  • Robust balance sheet and moderate leverage
  • Long‑term secular demand for reinsurance capacity

Key Metrics & Analysis

Financial Health

Revenue Growth-16.10%
Profit Margin8.71%
P/E Ratio12.1
ROE20.55%
ROA3.83%
Debt/Equity32.52
P/B Ratio2.5
Op. Cash Flow€5.3B
Free Cash Flow€3.3B
Industry P/E17.3

Technical Analysis

TrendNeutral
RSI49.1
Support€241.60
Resistance€258.20
MA 20€249.85
MA 50€247.18
MA 200€256.35
MACDBearish
VolumeStable
Fear & Greed Index76.91

Valuation

Fair Value€409.25
Target Price€283.93
Upside/Downside14.30%
GradeUndervalued
TypeBlend
Dividend Yield2.84%

Risk Assessment

Beta0.21
Volatility21.01%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.